Evaluation of 29 indicators for the prognosis of advanced non-small cell lung cancer with cytokine-induced killer cell therapy combined with chemotherapy

The aim of the present study was to evaluate 29 whole blood or serum indicators to identify factors able to predict clinical outcome following cytokine-induced killer (CIK) cell therapy combined with chemotherapy in patients with advanced non-small cell lung cancer (NSCLC), and to evaluate the 5-yea...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Exp Ther Med
Hlavní autoři: JIA, HEJIN, TIAN, YAPING, JIANG, CHAO GUANG, HAN, WEIDONG
Médium: Artigo
Jazyk:Inglês
Vydáno: D.A. Spandidos 2016
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4840551/
https://ncbi.nlm.nih.gov/pubmed/27168779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2016.3102
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky